Download Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center
General Information
Contact Information
Nonprofit
Vanderbilt-Ingram Cancer Center
Address
691 Preston Building
Nashville, TN 37232
Phone
(615) 936-5847
Fax
615 936-0236
Web Site
Web Site
Facebook
Facebook
Twitter
Twitter
Email
[email protected]
At A Glance
Year of Incorporation
1993
1
Mission & Impact
Statements
Mission
The mission of the Vanderbilt-Ingram Cancer Center is to alleviate cancer death and suffering through
pioneering research; innovative patient-centered care; and evidence-based prevention, education and
community initiatives.
Background
Vanderbilt University Medical Center has been at the forefront of groundbreaking cancer research and treatment
for decades. This legacy began with the work of Nobel laureates Earl Sutherland and Stanley Cohen, whose
research in cell communication, growth and dissemination are the foundation of many of today's breakthroughs
in cancer treatment. Building on that history, the Vanderbilt Cancer Center was formally established in 1993
under the leadership of Dr. Hal Moses. The Center consolidated all cancer-related research, treatment,
education and outreach at Vanderbilt with the immediate objective of joining the ranks of the premier institutions
designated as a Comprehensive Cancer Center by the National Cancer Institute (NCI). Two years later,
Vanderbilt became the youngest center to go from creation to designation with its initial status as a "clinical
cancer center." In 1999, Nashville's Ingram family made a transformational gift in honor of the late E. Bronson
Ingram, philanthropist, businessman and civic leader. The center became known as the Vanderbilt-Ingram
Cancer Center (VICC) in recognition of this important partnership.
In 2001, the Center earned NCI's top distinction as a Comprehensive Cancer Center, and remains one of only a
fraction of such centers in the United States. In 2008, Jennifer A. Pietenpol, Ph.D., Vanderbilt Professor of
Biochemistry, Cancer Biology and Otolaryngology, was named Director of the VICC. Later that year, President
Obama appointed her to serve a six-year term on the NCI’s National Cancer Advisory Board. In 2007, the
Center was invited to join the prestigious National Comprehensive Cancer Network, a non-profit alliance of the
nation’s top centers. These centers are recognized as being at the forefront of cancer diagnosis, treatment, and
support care and leading the way at conducting ground-breaking research. In July 2010, the VICC launched the
Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast to offer cancer
patients routine genotyping of their tumors at the DNA level. The Center continues to be a national leader in
precision medicine. In 2015, the Center successfully renewed its Comprehensive Cancer Center designation
and was recognized by its peers and the NCI as one of the very best Centers in the country.
2
Impact
The Vanderbilt-Ingram Cancer Center (VICC) is a national leader in patient care and research. One of the top
cancer centers in the nation; in 2015 the National Cancer Institute renewed VICC’s designation as a
Comprehensive Cancer Center – the only one in Tennessee that cares for adults as well as children. U.S. News
and World Report consistently lists Vanderbilt as one of the Best Cancer Hospitals in the nation. Patients
treated at VICC and their affiliated hospitals have access to top specialists in all types of cancer, from the more
common to the rare and to innovative therapies through clinical trials that may not be available at community
hospitals.
Members of the VICC are highly talented, creative, and regarded investigators in the cancer research
community. These investigators bring in over $130M annually in extramural grant funding, publish cancer
discoveries in the top journals, educate and mentor the next generation of physicians and researchers, hold
leadership roles in many national organizations, and are recognized nationally with awards and honors by their
peers. In addition, Vanderbilt-Ingram has been consistently recognized by the NCI as a Specialized Program of
Research Excellence in both GI and Breast Cancer.
In the past several years, the VICC has become one of the lead academic institutions to implement tumor
genotyping to identify “actionable” tumor mutations in patients, and, importantly, to integrate this genotyping into
clinical care decision-making. At VICC, tumor genotyping information is integrated into the patients’ medical
record with an informatics tool, My Cancer Genome (MCG), to help physicians understand the clinical
significance of genotyping results. Developed by VICC investigators, MCG (mycancergenome.org) provides
information about the detected mutation(s), discusses the therapies for tumors with respective genotypes and
lists clinical trials available at VICC and worldwide for particular diseases.
VICC investigators are studying the biological mechanisms that lead to treatment resistance in melanoma.
V600
Approximately half of all melanoma patients have tumors that harbor a BRAF
gene mutation. Therapies
that target BRAF are usually effective, but within a few months nearly all patients develop resistance to the
therapy and their cancer progresses. Investigators at the VICC found a variety of genetic mutations that lead to
this acquired resistance. This study provides insights into strategies to address treatment resistance.
For the first time, VICC investigators used a cancer patient’s own re-engineered immune cells to treat a form of
blood cancer by stimulating the immune system. The new CAR-T investigational therapy is being tested in a
clinical trial for patients with aggressive non-Hodgkin Lymphoma (NHL). VICC is the first cancer center in
Tennessee to treat a patient with the new investigational technology.
Investigators at the VICC continue a landmark investigation tracking the cancer and other disease experience of
a cohort of nearly 86,000 adults in the southeastern United States. The Southern Community Cohort Study
(SCCS), by design, has among the highest representation of African Americans compared to other cohort
studies, and is poised to address scientific questions about the causes of both common and rare cancers in
underrepresented minority populations, as well as the health disparities that exist in these populations.
In the coming years, the VICC will continue to support innovative cancer research and expand upon select
areas of research for continued translation of discoveries to the patient. There will be a major emphasis on
focused expansion of research areas through recruitment of talented investigators that can further integrate
basic research with clinical, epidemiological and population-based research initiatives. There will be continued
focus on cancer drug discovery and imaging, expansion of hematologic malignancies and agile development of
informatics tools to support research, clinical genomics and point-of-care decision-making. In doing so, we will
further strengthen the position of VICC, a matrix cancer center, within the university, region and nation as a top
provided of quality cancer care.
3
Needs
According to the National Cancer Institute, approximately 39.6 percent of men and women will be diagnosed
with cancer at some point during their lifetimes. Virtually no one is left untouched by the impact of this disease.
A cancer diagnosis is life-altering for both the patient and their family.
Giving to the Vanderbilt-Ingram Cancer Center (VICC) helps us continue to make a difference in the lives of
countless individuals facing a cancer diagnosis. Through generous gifts made by donors, the VICC is able to
accelerate the development of diagnostic tests and novel treatment options; recruit talented physicians and
scientists in all fields of cancer research and care; enhance existing and develop new prevention programs that
reach a broad population; develop programs to support cancer survivors and their families; and provide patients
with access to state-of-the-art facilities, enhancing the approach to cancer care and delivery. VICC is driven to
excel and continue to lead in the translation of new discoveries from bench to bedside and back to the bench.
Gifts large and small keep VICC on the leading edge of world-class health care and discovery.
Giving to the Vanderbilt-Ingram Cancer Center (VICC) helps us continue to make a difference in the lives of
countless individuals facing a cancer diagnosis. Through generous gifts made by donors, the VICC is able to
accelerate the development of diagnostic tests and novel treatment options; recruit top physicians and scientists
in all fields of cancer care and research; enhance existing and develop new prevention programs that reach a
broad population; develop programs to support cancer survivors and their families; and provide patients with
access to state-of-the-art facilities, enhancing the approach to cancer care and delivery.
Gifts large and small keep VICC on the leading edge of world-class health care and discovery.
Other ways to donate, support, or volunteer
Cancer and its impact on the patient and loved ones are too daunting a health challenge to be conquered easily
or without a true team effort. You can be a part of that team - and part of conquering cancer - by making a
charitable contribution to support cancer research or patient support. Your gift can make a huge difference in
the lives of cancer patients and their families, today and in the future.
• To make a gift
• To request information about other gifts, including cash, securities, memorial, tribute, gift annuity, charitable
remainder trust or other gifts, please call Vanderbilt-Ingram’s Development Office at 615-936-0233 or 800288-0028 or email us at [email protected].
• Contributions may also be mailed to:
Vanderbilt-Ingram Cancer Center
c/o Gifts Processing
PMB 407727
2301 Vanderbilt Place
Nashville, TN 37240-7727
• Find out more about Donor Supported Research
• Find out how to Volunteer
Service Categories
Primary Organization Category
Health Care / Speciality Hospitals
Secondary Organization Category
Medical Research / Cancer Research
Tertiary Organization Category
Diseases Disorders & Medical Disciplines / Cancer
Areas of Service
Areas Served
4
KY
TN
National
We treat patients largely from the Southeast region of the United States. We are also the cancer center of
choice for patients from around the country seeking treatment for specific cancers, particularly those that are
rare or aggressive.
CEO Statement
A personal experience is often the catalyst for private gifts of millions that will allow cancer scientists to do
everything from prove the value of an untested idea to harvest tissue samples that will be used for years in
research studies. Some donors attach very specific uses to their dollars. But others – the Ingram Foundation as
an example – give with the only restriction that the cancer center put the funds where they will have the biggest
impact. Vanderbilt-Ingram uses outside peer review to help prioritize projects based on scientific merit. Unlike
governmental funding, private money is often used to seed and nurture early ideas that are considered a bit
riskier to support. Private money accelerates discoveries jump-starts the contributions of exceptional,
earlycareer scientists. Private funds also support the less glamorous but absolutely essential tasks of the
research process, such as collecting and storing tissue and blood samples. We believe these biological
storehouses hold the key that will unlock the individualization of cancer diagnosis and treatment in years to
come. Vanderbilt-Ingram can begin to dissect genetic and molecular patterns that are predictive of cancer, an
effort that has gained impetus from the quick turnaround capabilities of today’s advanced technologies. Using
funds to find the roots of cancer will put us in a strong position to develop simple screening tests. The
sequencing of the human genome and other recent scientific advances has made this a truly promising era of
medical research. But the technology and talent needed to fulfill that promise are expensive. As the funds from
the NIH become scarcer in the face of a flat-if-not-decreasing budget, the role of philanthropy becomes even
more critical to keeping the science moving forward and capitalizing on the investment made in recent years.
We have the opportunity to make medical breakthroughs. It is all determined by how much money we have to
perform the work.
5
Programs
Programs
Director's Fund
Description
Cancer science is on the brink of unparalleled breakthroughs, and the
Vanderbilt-Ingram Cancer Center is uniquely positioned to help change
the course of this devastating disease. Funding for novel research,
however, is threatened if we must rely on traditional sources for support.
The majority of cancer research is funded by the National Cancer Institute
(NCI). Grants from the NCI are awarded to doctors and scientists based
upon the scientific merit of projects and substantiating research data. Our
Director's Fund gives VICC researchers the opportunity to test novel
approaches and acquire the necessary data needed for a successful
proposal. Funding supports promising projects with a goal of translating
new discoveries. The VICC has an impressive track record of new
projects started by private donations that have gone on to secure
substantial funding and produce important, groundbreaking discoveries in
colon, breast and lung cancer.
Population Served
,,
Discovery Grants
Description
Discovery Grants provide crucial funding to accelerate bold, innovative
research ideas. Whether contributing $50 or $50K, donors can support the
early stages of major new research initiatives, enabling these researchers
and scientists to obtain important data giving direction to future research.
Historically, discovery grants provide a significant return on investment, in
that they directly contribute to researchers securing substantive future
grant funds. The Vanderbilt-Ingram Cancer Center (VICC) Ambassadors,
a dynamic group that fundraises for discovery grants to promising
researchers at VICC, has awarded approximately $630,000 since 2009. In
those five years, that investment in new research initiatives has enabled
recipients to secure nearly $12M in follow-on funding from leading
research institutions such as the National Cancer Institute, National
Institutes of Health, and the Department of Defense.
Population Served
,,
6
Patient and Family Education and Support Resources
Description
The Vanderbilt-Ingram Cancer Center (VICC) strives to treat the physical,
emotional and practical needs of cancer patients and their caregivers
through educational and support programs. The Patient and Family
Resource Center is a one-stop information resource for cancer-related
issues for anyone who has been touched by cancer. It includes free
brochures, pamphlets and access to web-based information. Each newly
diagnosed cancer patient treated at VICC receives an educational,
individually-tailored notebook including information about cancer care,
resources and support. The Vanderbilt Cancer Wellness Program
promotes the health and wellbeing of those touched by cancer through
interactive, individualized, and comprehensive programs. Examples of
programs include: gentle movement classes; survivorship clinic; hereditary
risk clinic; fitness consults; lymphedema therapy; acupuncture; massage
therapy; yoga; smoking cessation and nutritional counseling.
Population Served
,,
Precision Medicine
Description
Vanderbilt-Ingram Cancer Center (VICC) is focused on delivering
precision cancer medicine to its patients. Precision medicine is when the
molecular variants of a patient’s individual tumor, such as gene mutations,
are used to determine the best course of treatment—to its patients. In
2011, VICC launched My Cancer Genome, a website that serves this goal
by enabling cancer patients, their doctors, and cancer researchers to
quickly access up-to-date information about how cancer-related molecular
variants can affect the course of cancer treatment. Each week, My Cancer
Genome provides information on cancer mutations, therapies, clinical
trials, and precision medicine to more than 9,000 people around the
world—less than half of whom are in the United States. When My Cancer
Genome began in 2010, it covered only a few genes and mutations in two
cancer types. It now covers more than 300 variants, 820 genes, 22 cancer
types, and 550 drugs for a total of about 1,500 pages. My Cancer
Genome is once again in the process of transforming the way it generates
and maintains content, so that it can provide more content, more quickly,
so that patients can get the information they need to make the best
treatment decisions sooner.
Population Served
,,
7
Survivorship
Description
Surviving cancer is a milestone accomplishment. Thanks to innovative
research and improved treatments, there are almost 13 million cancer
survivors alive today. By 2020, it is expected that there will be two million
new cancer survivors every year in the United States. The rise in survival
rates to almost 80 percent for children and 65 percent for adults has
created a new challenge for health care providers today: providing
appropriate comprehensive follow-up care for the increasing numbers of
cancer survivors. Cancer survivors often face physical, emotional, social,
and financial challenges as a result of their diagnosis and treatment.
Vanderbilt’s REACH (Research, Education, Advocacy, Care, Health)
Survivorship Program focuses on improving health outcomes in children
and adults living with, through, and after cancer. The overall goal is to
decrease the burden of cancer by developing a well-integrated program of
education, advocacy, clinical care, and interdisciplinary research, thus
creating a positive community of survivors and their families. Vanderbilt’s
REACH Survivorship Program serves all survivors regardless of age, type
of cancer, or treatment location.
Population Served
,,
CEO Comments
The Vanderbilt-Ingram Cancer Center is the organization without walls that unites all of the cancer-related
activities of Vanderbilt University and Medical Center, including clinical care, research and education. The
number of staff listed above represents a tiny fraction of our team -- in truth, the Center unites more than 300
faculty and more than 1,000 staff in cancer clinical units and departments in Vanderbilt Hospital and Clinic, the
Monroe Carell Jr. Children’s Hospital at Vanderbilt, in Williamson and Montgomery counties, and in more than
100 research laboratories across the campus. Formed in 1993, the Center is one of an elite group of 45
National Cancer Institute Comprehensive Cancer Centers and a member of the National Comprehensive
Cancer Network, a non-profit alliance of 21 leading centers working together to improve the quality of cancer
care for patients everywhere. The Center provides multi-disciplinary care for all cancers, with special strength in
clinical trials; colorectal, lung, breast, prostate, head/neck, kidney cancers; leukemias and lymphomas; and
sarcomas. Our research focuses on translation -- linking discovery and delivery of care for the benefit of patients
-- and in areas where we can have the greatest impact on death and suffering from cancer, including early
detection and prevention and development of innovative, more personalized and targeted therapies. The Center
is consistently listed among the best places for cancer care by U.S. News & World Report.
8
Governance
Board Chair
Board Chair
Orrin Ingram
Company Affiliation
Ingram Industries
Term
Apr 2007 to Apr 2016
Board Members
Name
Affiliation
Status
Carolyn Aldige
Cancer Research & Prevention
Foundation
Voting
Helen Alexander
Community Volunteer
Voting
Yvette Boyd
Community Volunteer
Voting
Tommy Boyle
Community Volunteer
Voting
James C. Bradford
Community Volunteer
Voting
John F. Brock IV
Community Volunteer
Voting
Dorothy Brotherton
Community Volunteer
Voting
Andrew Byrd
Andrew W. Byrd & Co. LLC
Voting
Doreatha Churchwell
Community Volunteer
Voting
David Corlew
Community Volunteer
Voting
Rebecca Brock Dixon
Community Volunteer
Voting
Farzin Ferdowsi
Community Volunteer
Voting
Beth Franklin
Multi-Task Solutions, LLC
Voting
Mimi Gracida
Community Volunteer
Voting
Janet Greene
Community Volunteer
Voting
Donna Hall
Community Volunteer
Voting
Dell Hancock
Community Volunteer
Voting
Orrin Ingram
Ingram Industries
Voting
Ronnie James
Community Volunteer
Voting
Douglas H. Joyce
Community Volunteer
Voting
Robert Lipman
Community Volunteer
Voting
Tony Martell
Sony Music
Voting
Kathy Mattea
Musician
Voting
Albert Menefee III
Menefee Equipment Co.
Voting
Carol O'Hare
Community Volunteer
Voting
Cano Ozgener
Community Volunteer
Voting
Clay Petrey
Ayers Asset Mgmt. Inc.
Voting
James Congdon Seabury III
Community Volunteer
Voting
Susan Simons
Community Volunteer
Voting
Board Demographics - Ethnicity
African American/Black
2
9
Asian American/Pacific Islander
0
Caucasian
27
Hispanic/Latino
0
Native American/American Indian
0
Other
0
Board Demographics - Gender
Male
15
Female
14
Unspecified
0
Governance
Board Term Lengths
3
Board Term Limits
2
Board Meeting Attendance %
70%
Written Board Selection Criteria?
No
Written Conflict of Interest Policy?
Under Development
Percentage Making Monetary Contributions
86%
Percentage Making In-Kind Contributions
86%
Constituency Includes Client Representation
No
Number of Full Board Meetings Annually
2
Standing Committees
Development / Fund Raising
Community Outreach / Community Relations
CEO Comments
The Vanderbilt-Ingram Cancer Center is the umbrella organization that unites all of the cancer-related activities
of Vanderbilt University and Medical Center, including clinical care, research and education. While the number
of staff who have the Center as a “home department” is small, the Center unites more than 300 faculty and
more than 1,000 staff in cancer clinical areas in Vanderbilt Hospital and Clinic, the Monroe Carell Jr. Children’s
Hospital at Vanderbilt, in Williamson and Montgomery counties, and in more than 100 research laboratories
across the campus. Formed in 1993, the Center is one of an elite group of 45 National Cancer Institute
Comprehensive Cancer Centers and a member of the National Comprehensive Cancer Network, a non-profit
alliance of 21 leading centers working together to improve the quality of cancer care for patients everywhere.
10
Management
Executive Director/CEO
Executive Director
Jennifer A. Pietenpol Ph.D.
Term Start
Jan 2008
Email
[email protected]
Former CEOs
Name
Term
Raymond DuBois M.D., Ph.D.
2005 - 2007
Harold Moses M.D.
1993 - 2004
Staff
Full Time Staff
0
Part Time Staff
0
Volunteers
0
Contractors
0
Retention Rate
93%
Plans & Policies
Does the organization have a documented Fundraising Plan?
Under Development
Does the organization have an approved Strategic Plan?
Yes
In case of a change in leadership, is a Management Succession plan in place?
Yes
Does the organization have a Policies and Procedures Plan?
Yes
Does the organization have a Nondiscrimination Policy?
Yes
Does the organization have a Whistle Blower Policy?
Yes
Does the organization have a Document Destruction Policy?
Yes
Affiliations
Affiliation
Year
Nashville Area Chamber of Commerce
2008
Williamson County Chamber of Commerce
2008
Bridges to Care - Safety Net Provider
2008
11
Community Shares
2008
Rural Health Association of Tennessee
2008
Tennessee Cooperative Cancer Coalition
2003
National Association of Social Workers
2008
Chamber of Commerce
2008
Association of American Medical Colleges
2008
Tennessee Hospital Association
2008
External Assessments and Accreditations
Assessments/Accreditations
Year
Accreditation Council for Continuing Medical
Education - Accreditation
2015
Centers for Medicare and Medicaid Services (U.S.
Department of Health and Human Services) Medicare Certification
2015
Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) - Behavioral Health Care
Accreditation
2015
Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) - Hospital Accreditation
2015
Awards
Awards
Award/Recognition
Organization
Year
Specialized Programs of Research National Cancer Institute
Excellence in Breast Cancer
2013
Designation/membership
National Comprehensive Cancer
Network
2015
Comprehensive Cancer Center
Designation
National Cancer Institute
2015
Best Cancer Hospitals
US News & World Report
2015
Specialized Programs of Research National Cancer Institute
Excellence in GI Cancer
2012
Senior Staff
Scott Hiebert Ph.D.
Title
Associate Director for Basic Research and Shared Resources
Experience/Biography
Dan Beauchamp M.D.
Title
Deputy Director
Experience/Biography
12
William Blot Ph.D.
Title
Associate Director for Population-Based Research
Experience/Biography
Lauren Hackett M.P.A.
Title
Executive Director for Administration and Chief Business Officer
Experience/Biography
Ann Richmond Ph.D.
Title
Associate Director for Research Education
Experience/Biography
Xiao-Ou Shu M.D., Ph.D., M.P.H.
Title
Associate Director for Global Health
Experience/Biography
Yu Shyr Ph.D.
Title
Associate Director for Quantitative Sciences
Experience/Biography
Carlos Arteaga M.D.
Title
Associate Director for Clinical Research
Experience/Biography
CEO Comments
The Vanderbilt-Ingram Cancer Center is the umbrella organization that unites all of the cancer-related activities
of Vanderbilt University and Medical Center, including clinical care, research and education. While the number
of staff who have the Center as a “home department” is small, the Center unites more than 300 faculty and
more than 1,000 staff in cancer clinical areas in Vanderbilt Hospital and Clinic, the Monroe Carell Jr. Children’s
Hospital at Vanderbilt, in Williamson and Montgomery counties, and in more than 100 research laboratories
across the campus. Formed in 1993, the Center is one of an elite group of National Cancer Institute
Comprehensive Cancer Centers and a member of the National Comprehensive Cancer Network, a non-profit
alliance of leading centers working together to improve the quality of cancer care for patients everywhere.
13
Financials
Fiscal Year
Fiscal Year Start
July 01 2015
Fiscal Year End
June 30 2016
Projected Revenue
$0.00
Projected Expenses
$0.00
Endowment Value
$0.00
Endowment Spending Policy
N/A
Endowment Spending Percentage (if selected)
0%
Detailed Financials
Revenue and Expenses
Fiscal Year
Total Revenue
Total Expenses
Revenue Sources
Fiscal Year
Foundation and Corporation
Contributions
Government Contributions
Federal
State
Local
Unspecified
Individual Contributions
Indirect Public Support
Earned Revenue
Investment Income, Net of Losses
Membership Dues
Special Events
Revenue In-Kind
Other
2009
$33,879,544
$35,309,858
2008
$46,155,327
$38,660,178
2007
$39,299,933
$35,772,034
2009
$6,551,504
2008
$15,116,340
2007
$8,391,214
$18,178,853
$18,178,853
$0
$0
$0
$8,438,689
$0
$0
$142,480
$0
$0
$0
$568,018
$22,383,641
$22,383,641
$0
$0
$0
$6,284,547
$0
$0
$57,805
$0
$0
$0
$2,312,994
$20,913,883
$20,913,883
$0
$0
$0
$2,875,504
$0
$0
$432,933
$0
$0
$0
$6,686,399
14
Expense Allocation
Fiscal Year
Program Expense
Administration Expense
Fundraising Expense
Payments to Affiliates
Total Revenue/Total Expenses
Program Expense/Total Expenses
Fundraising Expense/Contributed
Revenue
Assets and Liabilities
Fiscal Year
Total Assets
Current Assets
Long-Term Liabilities
Current Liabilities
Total Net Assets
Short Term Solvency
Fiscal Year
Current Ratio: Current Assets/Current
Liabilities
Long Term Solvency
Fiscal Year
Long-Term Liabilities/Total Assets
Top Funding Sources
Fiscal Year
Top Funding Source & Dollar Amount
Second Highest Funding Source & Dollar
Amount
Third Highest Funding Source & Dollar
Amount
2009
$32,909,777
$2,400,081
$0
$0
0.96
93%
0%
2008
$37,296,779
$1,363,399
$0
$0
1.19
96%
0%
2007
$34,360,860
$1,411,174
$0
$0
1.10
96%
0%
2009
$0
$0
$0
$0
$0
2008
$0
$0
$0
$0
$0
2007
$0
$0
$0
$0
$0
2009
--
2008
--
2007
--
2009
--
2008
--
2007
--
2009
---
2008
---
2007
---
--
--
--
Capital Campaign
Is the organization currently conducting a Capital
Campaign for an endowment or the purchase of a
major asset?
No
Capital Campaign Goal
$0.00
Capital Campaign Anticipated in Next 5 Years?
No
State Charitable Solicitations Permit
TN Charitable Solicitations Registration
Exempt - Expires 0
Registration
No 0
GivingMatters.com Financial Comments
Financial figures for Ingram Cancer Center are taken from internal documents. Vanderbilt University submits
one 990 and has one audit. The departments/programs are not isolated in the audit or 990. Vanderbilt
Department of Finance reviewed documents provided by Ingram Cancer Center to GivingMatters.com. Assets
are not included in GivingMatters.com as all assets belong to Vanderbilt. Fundraising expenses are accounted
for in a different department and were not provided to GivingMatters.com.
15
Financial documents provided by KPMG.
Comments provided by Amy McDaniel 08/2010.
Created 04.30.2017.
Copyright © 2017 The Community Foundation of Middle Tennessee
16